Zevra Therapeutics Inc (ZVRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -36,547 | -16,622 | -46,049 | -26,157 | -15,790 |
| Depreciation Amortization | 3,124 | 1,562 | 1,006 | 219 | 157 |
| Accounts receivable | 8,430 | 9,072 | -9,078 | -1,628 | -5,734 |
| Other Working Capital | 1,631 | -148 | 5,883 | 8,424 | 667 |
| Other Operating Activity | -11,912 | -10,029 | 14,703 | 1,765 | 7,951 |
| Operating Cash Flow | $-35,274 | $-16,165 | $-33,535 | $-17,377 | $-12,749 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | -2,325 | 16,533 |
| PPE Investments | N/A | N/A | -296 | -224 | -52 |
| Net Acquisitions | N/A | N/A | -30,401 | N/A | N/A |
| Purchase Of Investment | -129 | N/A | -45,814 | -25,426 | N/A |
| Sale Of Investment | 14,793 | 14,793 | 59,121 | N/A | N/A |
| Investing Cash Flow | $14,664 | $14,793 | $-17,390 | $-27,975 | $16,481 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 60,072 | N/A | 43,687 | 40,057 | 14,056 |
| Debt Repayment | -43,131 | N/A | -18,100 | -13,369 | -13,574 |
| Common Stock Issued | 1,697 | 1,217 | 6,324 | 219 | 166 |
| Common Stock Repurchased | N/A | N/A | -3,447 | -3,447 | -3,447 |
| Other Financing Activity | -2,091 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $16,547 | $1,217 | $28,464 | $23,460 | $-2,799 |
| Exchange Rate Effect | 274 | -45 | 44 | -305 | -203 |
| Beginning Cash Position | 43,049 | 43,049 | 65,466 | 65,466 | 65,466 |
| End Cash Position | 39,260 | 42,849 | 43,049 | 43,269 | 66,196 |
| Net Cash Flow | $-3,789 | $-200 | $-22,417 | $-22,197 | $730 |
| Free Cash Flow | |||||
| Operating Cash Flow | -35,274 | -16,165 | -33,535 | -17,377 | -12,749 |
| Capital Expenditure | 0 | N/A | -296 | -224 | -52 |
| Free Cash Flow | -35,274 | -16,165 | -33,831 | -17,601 | -12,801 |